Increased expression of non-interleukin-2 T cell growth factors and their implications during liver allograft rejection in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 7, 2007, Pages 1141-1147

  Wang, Wei Lin ^b   Yao, Min Ya ^b   Jin, Jing ^b   Jia, Chang Ku ^b   Gao, Liang Hui ^b   Xie, Hai Yang ^b   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

Allograft rejection; Interleukin 13; Interleukin 15; Interleukin 7; Liver transplantation

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 7; MESSENGER RNA;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CELL DAMAGE; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC GRAFT REJECTION; CHRONOLOGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG MEGADOSE; EXPERIMENTAL MODEL; HEPATIC DUCT; HISTOPATHOLOGY; IMMUNOREGULATION; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

EID: 34347378343     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04925.x     Document Type: Article

References (43)

1. Li XC, Li Y, Zheng XX, Strom TB. Regulation of transplantation tolerance by T-cell growth factors. Curr. Opin. Organ Transplant. 2000 5 : 16 24.
2. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J. Exp. Med. 1991 174 : 493 6.
3. Vincenti F, Kirkman R, Light S et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N. Engl. J. Med. 1998 338 : 161 5.
4. Nashan B, Moore R, Amlot P et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997 350 : 1193 8.
5. Liu CL, Fan ST, Lo CM et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl. 2004 6 : 728 33.
6. Calmus Y, Scheele JR, Gonzalez-Pinto I et al. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Liver Transpl. 2002 2 : 123 31.
7. Van Gelder T, Baan CC, Balk AH et al. Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans. Transplantation 1998 65 : 405 510.
8. Fehniger T, Caligiuri M. Interleukin-15: Biology and relevance to human disease. Blood 2001 97 : 14 32.
9. Li XC, Schachter AD, Zand MS et al. Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. Transplantation 1998 66 : 265 8.
10. Li XC, Roy-Chaudhury P, Hancock WW et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J. Immunol. 1998 161 : 890 6.
11. Baan CC, Knoop CJ, van Gelder T et al. Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. Transplantation 1999 67 : 870 6.
12. Pavlakis M, Strehlau J, Lipman M, Shapiro M, Maslinski W, Strom TB. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 1996 62 : 543 5.
13. Baan CC, Niesters HGM, Metselaar HJ et al. Increased intragraft IL-15 mRNA expression after liver transplantation. Clin. Transplant. 1998 12 : 212 18.
14. Conti F, Frappier J, Dharancy S et al. Interleukin-15 production during liver allograft rejection in humans. Transplantation 2003 76 : 210 16.
15. Smith XG, Bolton EM, Ruchatz H, Wei XQ, Liew FY, Bradley JA. Selective blockade of IL-15 by soluble IL-15 receptor α-chain enhances cardiac allograft survival. J. Immunol. 2000 165 : 3444 50.
16. Baan CC, Haperen MB, van Riemsdijk IC, van der Plas AJ, Weimar W. IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies. Transplant. Proc. 2001 33 : 2244 6.
17. Warle MC, Farhan A, Metselaar HJ et al. In vitro cytokine production of TNFα and IL-13 correlates with acute liver transplant rejection. Hum. Immunol. 2001 62 : 1258 65.
18. Torrealba JR, Fernandez LA, Kanmaz T et al. Immunotoxin treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation 2003 76 : 524 30.
19. Allan JS, Wain JC, Schwarze ML et al. Modeling chronic lung allograft rejection in miniature swine. Transplantation 2002 73 : 447 53.
20. Lee RS, Yamada K, Houser SL et al. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc. Natl Acad. Sci. USA 2001 98 : 3276 81.
21. Noris M, Azzollini N, Pezzotta A et al. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. J. Am. Soc. Nephrol. 2001 12 : 1937 46.
22. Soots A, Lautenschlager I, Krogerus L, Saarinen O, Ahonen J. An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression. Transplantation 1999 65 : 42 6.
23. Kamada N, Calne RY. A surgical experience with five hundred and thirty liver transplants in the rat. Surgery 1983 93 : 64 9.
24. Freese DK, Snover DC, Sharp HL, Gross CR, Kay Savick S, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features. Hepatology 1991 13 : 882 91.
25. Conti F, Dousset B, Archambeau D, Louvel A, Houssin D, Calmus Y. Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients. Transplantation 1995 60 : 1104 8.
26. Wiesner RH, Demetris AJ, Belle SH et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998 28 : 638 45.
27. Bumgardner GL, Orosz CG. Transplantation and cytokines. Semin. Liver Dis. 1999 19 : 189 204.
28. Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB. IL-2 knockout recipient mice reject islet cell allografts. J. Immunol. 1995 155 : 489 98.
29. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000 288 : 675 8.
30. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory phenotype CD8+ T cells in vivo by IL-15. Immunity 1998 8 : 591 9.
31. Alleva DG, Kaser SB, Monroy MA, Fenton MJ, Beller DI. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 1997 159 : 2941 51.
32. Fehniger TA, Suzuki K, Ponnappan A et al. Fatal leukemia in interleukin-15 transgenic mice follows early expansions in natural killer and memory phenotype CD8 (+) T cells. J. Exp. Med. 2001 193 : 219 31.
33. Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of IL-2 receptor. J. Exp. Med. 1994 180 : 1395 403.
34. Kanegane H, Tosato G. Activation of naive and memory T cells by interleukin-15. Blood 1996 88 : 230 5.
35. Angiolillo AL, Kanegane H, Sgadari C, Reaman GH, Tosato G. Interleukin-15 promotes angiogenesis in vivo. Biochem. Biophys. Res. Commun. 1997 233 : 231 7.
36. Armitage RJ, Macduff BM, Ziegler SF, Grabstein KH. Multiple cytokine secretion by IL-7 stimulated human T cells. Cytokine 1992 4 : 461 9.
37. Zoll B, Lefterova P, Csipai M et al. Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12. Cancer Immunol. Immunother. 1998 47 : 221 6.
38. Callard RE, Matthews DJ, Hibbert L. IL-4 and IL-13 receptors: are they one and the same? Immunol. Today 1996 17 : 108 10.
39. Li XC, Strom TB. T-cell growth factors and the allograft response. Curr. Opin. Organ Transplant. 2003 8 : 19 24.
40. Conti F, Calmus Y, Rouer E et al. Increased expression of interleukin-4 during liver allograft rejection. J. Hepatol. 1999 30 : 935 43.
41. Otto C, Kauczok J, Martens N et al. Mechanisms of tolerance induction after rat liver transplantation: intrahepatic CD4 (+) T cells produce different cytokines during rejection and tolerance in response to stimulation. J. Gastrointest. Surg. 2002 6 : 455 63.
42. Bamford RN, DeFilippis AP, Azimi N, Kurys G, Waldmann TA. The 50 untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J. Immunol. 1998 160 : 4418 26.
43. Warle MC, Farban A, Metselaar HJ et al. Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl. 2002 8 : 603 11.